Company Comparison
Editas Medicine vs BioAnalytics Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Editas Medicine | BioAnalytics Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | located in Cambridge, Massachusetts | Cambridge |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Editas Medicine
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
BioAnalytics Pro
Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.
Key Investors
Editas Medicine
BioAnalytics Pro
No investors listed.
Sector Overlap
Both Editas Medicine and BioAnalytics Pro operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.